Key Events This Week
15 Jun: Lower circuit hit amid heavy selling (Rs.157.18)
16 Jun: Locked lower circuit for second consecutive day (Rs.149.33)
17 Jun: Upper circuit surge reversing downtrend (Rs.156.79)
19 Jun: Another upper circuit close amid strong buying (Rs.162.07)

Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent
2026-06-19 12:00:09At Rs 162.07, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 5% on 19 Jun 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent
2026-06-17 10:00:56At Rs 156.79, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 5.0% on 17 Jun 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 4.99% Loss — Sellers Queue, No Buyers in Sight
2026-06-16 10:00:16At Rs 149.33, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 4.99% on 16 Jun 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity.
Read full news article
Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight
2026-06-15 13:00:10At Rs 157.18, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 5.0% on 15 Jun 2026, with unfilled sell orders and a frozen price, signalling a pronounced imbalance between supply and demand in this micro-cap stock.
Read full news articleBafna Pharmaceuticals Gains 33.40%: 5 Key Factors Driving the Surge
2026-06-13 17:04:13
Key Events This Week
1 June: Upper circuit hit at Rs.140.45 (+4.81%)
2 June: Upper circuit hit again, closing at Rs.147.45 (+4.98%)
3 June: Third consecutive upper circuit at Rs.154.80 (+4.98%) and valuation downgrade noted
4 June: Fourth upper circuit day, closing at Rs.162.50 (+4.97%)
5 June: Fifth day surge with a 10.00% gain, closing at Rs.178.75
Bafna Pharmaceuticals Drops 6.99%: 7 Key Events Shaping the Week
2026-06-13 12:00:06
Key Events This Week
8 Jun: Upper circuit hit at Rs.196.60 (+9.99%) amid strong buying momentum
9 Jun: New 52-week high at Rs.215.7 and second upper circuit close at Rs.176.95 (-9.99%)
10 Jun: Golden Cross formation; stock hits lower circuit at Rs.165.86 (-4.97%)
11 Jun: Lower circuit hit again at Rs.157.57 (-5.0%) amid heavy selling
12 Jun: Week closes with third lower circuit at Rs.166.25 (-4.97%)

Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight
2026-06-12 10:00:14At Rs 165.45, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 5.0% on 12 Jun 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity.
Read full news article
Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight
2026-06-11 10:00:22At Rs 157.57, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 5.0% on 11 Jun 2026, with unfilled sell orders and a frozen price, signalling a day dominated by supply overwhelming demand.
Read full news articleBafna Pharmaceuticals Limited - Outcome of Board Meeting
14-Nov-2019 | Source : NSEBafna Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on November 13, 2019.
Reply to Clarification- Financial results
27-Aug-2019 | Source : NSE
| The Exchange had sought clarification from Bafna Pharmaceuticals Limited for the quarter ended 30-Jun-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is enclosed. |
Suspension of trading in equity shares
21-Aug-2019 | Source : NSE
| BAFNAPHARM: Members of the Exchange are hereby informed that the trading in Equity Shares of Bafna Pharmaceuticals Limited shall be suspended w.e.f. August 26, 2019 (i.e. closing hours of trading on August 23, 2019) on account of Reduction of Share Capital. |
Corporate Actions
No Upcoming Board Meetings
Bafna Pharmaceuticals Ltd has declared 6% dividend, ex-date: 19 Sep 13
No Splits history available
No Bonus history available
No Rights history available






